Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. 10-Q Report Quarterly Report
  2. 4 Insider Changes in Ownership
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. UPLOAD Other SEC-generated Letter
  10. EFFECT Other Notice of Effectiveness
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. UPLOAD Other SEC-generated Letter
  16. S-3 Offering Registration Statement
  17. S-3 Offering Registration Statement
  18. 4 Insider Changes in Ownership
  19. 8-K Event Executive or director change · Shareholder vote results
  20. DEF 14A Proxy Proxy Statement

Page 37 of 41 · 819 filings